The Biomarkers Consortium’s Cancer, Inflammation and Immunity, Metabolic Disorders and Neuroscience Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by the Biomarkers Consortium, as well as overseeing each individual project under its purview. The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.
| Henry Burch, M.D., NIH/NIDDK (Co-Chair)
Roberto Calle, M.D., Regeneron (Co-Chair) Vandana Sachdev, M.D., NIH/NHLBI (Co-Chair) Alexandre Akoulitchev, Ph.D., Oxford Biodynamics Niyana Barron-Avilez, Olink Nigel Beaton, Ph.D., Biognosys Jenny Blau, M.D., AstraZeneca Javed Butler, MD, University of Mississippi Xiping Cheng, Regeneron Matt Clancey, LapCorp Clayton Dehn, ERG Samuel Engel, M.D., Merck Klaus Engelke, Ph.D., BioClinica Mike Espey, PhD, NCI Josh Fessel, M.D., Ph.D., NCATS Céline Fournier, Ph.D., Echosens Gopi Ganji, Ph.D., GlaxoSmithKline Chris Hartshorn, PhD, NCI Stephanie Hennek, Ph.D., PathAI Julie Huang, Alector Claude Hughes, M.D., Ph.D., IQVIA Thomas Idorn, M.D., Ph.D., Novo Nordisk Lyndon Joseph, Ph.D., NIH/NIA Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S Helina Kassahun, M.D., Amgen Eunkyung Kauh, Ph.D., Merck Keith Kaufman, M.D., Merck Young S. Kim, Ph.D., NIH/NCI Kathy Landschulz, Ph.D., LabCorp Olof Dahlqvist Leinhard, Ph.D., AMRA Medical |
Derek McCartney, M.Sc., Biognosys
Mark Messenbaugh, JD, Somalogic Mike Montalto, Ph.D., PathAI Andrea Mortera, Empatica Antonella Napolitano, M.D., Ph.D., GlaxoSmithKline Mariaelena Occhipinti, MD, Ph.D., Radiomics Afshin Parsa, M.D., MPH, NIH/NIDDK Ketan Patel, D. Phil., Clarivate Aaron Pawlyk, PhD, NCHID Ale Pocai, Ph.D., Janssen Jelena Polajeva, Ph.D., Clarivate Josh Porter, Olink Jeff Reagan, Ph.D., Amgen James Rickard, M.Pharm, Richmond Research Institute Matthew Roe, M.D., AstraZeneca Anthony Samir M.D., MGH Arun Sanyal, M.D., VCU Aditi Saxena, Pfizer Michelle Slimko, M.P.H., R.D., NDC Gad Soffer, General Metabolics Pothur Srinivas, Ph.D., NIH/NHLBI Elizabeth Stafford, Ph.D., FDA/CDRH Paresh Thakker, Ph.D., Takeda Melissa Thomas, M.D., Ph.D., Eli Lilly Moises Torres-Gonzalez, Ph.D., National Dairy Council Megann Vaughn, M.B.A., LabCorp David R. Vera, Ph.D., University of California, San Diego Tony Wagner, PhD, Jazz Pharmaceuticals Joel Wommack, Ph.D., SomaLogic |